Bausch & Lomb (since 2010 stylized as Bausch + Lomb) is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company was founded in Rochester, New York, in 1853 by optician John Bausch and cabinet maker turned financial backer Henry Lomb. Until its sale in 2013, Bausch + Lomb was one of the oldest continually operating companies in the United States.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| BLCO | Bausch & Lomb Corp | 2025-10-16 15:10:04 | 14.86 | 0.01 | 0.1 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLCO | 0001860742 | Bausch & Lomb Corp | CA0717051076 | — | — | NYSE | 3851 | Ophthalmic Goods | 1231 | — | 520 APPLEWOOD CRESCENT | VAUGHAN | A6 | L4K 4B4 | CANADA | CA | 908-541-5456 | 520 APPLEWOOD CRESCENT, VAUGHAN, A6, L4K 4B4 | 520 APPLEWOOD CRESCENT, VAUGHAN, A6, L4K 4B4 | — | Medical instruments | 1853 | Brent Saunders | 12,900 | http://bausch.com | 598,093,552 | 353,803,959 | 353,865,790 | Bausch & Lomb (since 2010 stylized as Bausch + Lomb) is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company was founded in Rochester, New York, in 1853 by optician John Bausch and cabinet maker turned financial backer Henry Lomb. Until its sale in 2013, Bausch + Lomb was one of the oldest continually operating companies in the United States. | 2025-10-10 20:08:49 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 598,093,552 | -204,219,630 | -25.4539 | 352,470,796 | 1,478,553 | 0.4212 |
| 2023 | 802,313,182 | 199,565,741 | 33.1093 | 350,992,243 | 991,310 | 0.2832 |
| 2022 | 602,747,441 | 602,747,441 | 100 | 350,000,933 | 350,000,933 | 100 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 13,500 |
| 2023 | 13,300 |
| 2022 | 12,900 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 4,791,000,000 | 4,146,000,000 | 3,768,000,000 |
| Cost Of Revenue | 1,868,000,000 | 1,640,000,000 | 1,511,000,000 |
| Gross Profit | — | — | — |
| Research And Development Expenses | 343,000,000 | 324,000,000 | 307,000,000 |
| General And Administrative Expenses | 2,082,000,000 | 1,736,000,000 | 1,478,000,000 |
| Operating Expenses | 4,629,000,000 | 4,016,000,000 | 3,561,000,000 |
| Operating Income | 162,000,000 | 130,000,000 | 207,000,000 |
| Net Income | -317,000,000 | -260,000,000 | 6,000,000 |
| Earnings Per Share Basic | -0.9 | -0.74 | 0.02 |
| Earnings Per Share Diluted | -0.9 | -0.74 | 0.02 |
| Weighted Average Shares Outstanding Basic | 351,800,000 | 350,500,000 | 350,000,000 |
| Weighted Average Shares Outstanding Diluted | 351,800,000 | 350,500,000 | 350,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 305,000,000 | 331,000,000 | 354,000,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 1,026,000,000 | 839,000,000 | 724,000,000 |
| Inventories | 1,036,000,000 | 1,028,000,000 | 628,000,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 2,788,000,000 | 2,742,000,000 | 2,137,000,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 1,485,000,000 | 1,390,000,000 | 1,300,000,000 |
| Other Assets Non Current | 294,000,000 | 225,000,000 | 215,000,000 |
| Total Assets Non Current | 1,485,000,000 | 1,390,000,000 | 1,300,000,000 |
| Total Assets | 13,469,000,000 | 13,442,000,000 | 11,144,000,000 |
| Accounts Payable | 389,000,000 | 522,000,000 | 370,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 40,000,000 | 30,000,000 | 25,000,000 |
| Other Liabilities Current | 1,309,000,000 | 1,027,000,000 | 901,000,000 |
| Total Liabilities Current | 1,738,000,000 | 1,579,000,000 | 1,296,000,000 |
| Long Term Debt | 4,784,000,000 | 4,562,000,000 | 2,411,000,000 |
| Other Liabilities Non Current | 430,000,000 | 397,000,000 | 329,000,000 |
| Total Liabilities Non Current | 5,187,000,000 | 4,943,000,000 | 2,747,000,000 |
| Total Liabilities | 6,925,000,000 | 6,522,000,000 | 4,043,000,000 |
| Common Stock | 0 | 0 | 0 |
| Retained Earnings | -571,000,000 | -254,000,000 | 6,000,000 |
| Accumulated Other Comprehensive Income | -1,385,000,000 | -1,245,000,000 | -1,258,000,000 |
| Total Shareholders Equity | 6,473,000,000 | 6,850,000,000 | 7,033,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 436,000,000 | 382,000,000 | 379,000,000 |
| Share Based Compensation Expense | 92,000,000 | 74,000,000 | 62,000,000 |
| Other Non Cash Income Expense | 19,000,000 | 3,000,000 | 19,000,000 |
| Change In Accounts Receivable | 227,000,000 | 121,000,000 | 95,000,000 |
| Change In Inventories | 147,000,000 | 264,000,000 | 106,000,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 126,000,000 | 245,000,000 | 189,000,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 232,000,000 | -17,000,000 | 345,000,000 |
| Purchases Of Marketable Securities | 12,000,000 | 17,000,000 | 17,000,000 |
| Sales Of Marketable Securities | 14,000,000 | 16,000,000 | 22,000,000 |
| Acquisition Of Property Plant And Equipment | 291,000,000 | 181,000,000 | 175,000,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -412,000,000 | -2,109,000,000 | -215,000,000 |
| Tax Withholding For Share Based Compensation | 12,000,000 | 10,000,000 | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 631,000,000 | 2,276,000,000 | 2,440,000,000 |
| Repayment Of Long Term Debt | 430,000,000 | 161,000,000 | 13,000,000 |
| Other Financing Activities | -1,000,000 | -2,000,000 | — |
| Cash From Financing Activities | 178,000,000 | 2,078,000,000 | 81,000,000 |
| Change In Cash | -18,000,000 | -46,000,000 | 203,000,000 |
| Cash At End Of Period | 305,000,000 | 331,000,000 | 354,000,000 |
| Income Taxes Paid | 91,000,000 | 64,000,000 | 83,000,000 |
| Interest Paid | 415,000,000 | 238,000,000 | 132,000,000 |
| Fiscal Year | 2024 | 2023 |
|---|---|---|
| Earnings Per Share | -0.9 | -0.74 |
| Price To Earnings Ratio | -20.0667 | -23.0541 |
| Earnings Growth Rate | 21.6216 | -3,800 |
| Price Earnings To Growth Ratio | -0.9281 | 0.0061 |
| Book Value Per Share | 18.6015 | 19.7432 |
| Price To Book Ratio | 0.9709 | 0.8641 |
| Ebitda | 609,000,000 | 469,000,000 |
| Enterprise Value | 10,872,508,000 | 10,240,530,000 |
| Dividend Yield | — | — |
| Dividend Payout Ratio | — | — |
| Debt To Equity Ratio | 0.7452 | 0.6704 |
| Capital Expenditures | 531,000,000 | 472,000,000 |
| Free Cash Flow | -299,000,000 | -489,000,000 |
| Return On Equity | -0.049 | -0.038 |
| One Year Beta | 0.9204 | 0.9395 |
| Three Year Beta | 0.9933 | 1.0144 |
| Five Year Beta | 0.9933 | 1.0144 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| SAUNDERS BRENT L | Director, CEO and Chairman of the Board | 2025-08-05 | 4,231 | D | 736,925 |
| Hashad Yehia | EVP of R&D and CMO | 2025-08-05 | 17,715 | A | 134,454 |
| Bonnefoy Luc | President, Surgical | 2025-08-05 | 6,146 | A | 77,362 |
| Eldessouky Sam | EVP and CFO | 2025-08-05 | 42,517 | A | 320,816 |
| Munsch Frederick | SVP, Controller and CAO | 2025-08-05 | 7,529 | A | 77,733 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Blue Trust, Inc. | 2025-09-30 | 5,576 | 370 | 15.0703 |
| OSAIC HOLDINGS, INC. | 2025-06-30 | 7,910 | 608 | 13.0099 |
| Squarepoint Ops LLC | 2025-06-30 | 662,105 | 50,892 | 13.01 |
| State of Wyoming | 2025-06-30 | 177,938 | 13,677 | 13.01 |
| NOMURA HOLDINGS INC | 2025-06-30 | 16,342,915 | 1,256,181 | 13.01 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| AMG Funds IV | 2025-07-31 | CLASS Z Shares | ARSZX | 109,710 | 1,495,347.3 | 0.4307 |
| AMG Funds IV | 2025-07-31 | CLASS I SHARES | ARIMX | 109,710 | 1,495,347.3 | 0.4307 |
| AMG Funds IV | 2025-07-31 | CLASS N SHARES | ARSMX | 109,710 | 1,495,347.3 | 0.4307 |
| Invesco Exchange-Traded Fund Trust II | 2025-07-31 | Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF | PDN | 4,815 | 65,962.24 | 0.0185 |
| BNY Mellon ETF Trust | 2025-07-31 | BNY Mellon US Small Cap Core Equity ETF | BKSE | 1,454 | 19,818.02 | 0.0311 |